Medical research organization NAMSA said it has acquired Reimbursement Strategies, a Minneapolis-based consultancy focused on reimbursement, health economics and market access for the international life science industry.
Toledo, Ohio-based NAMSA is a medical device development firm that offers integrated laboratory testing, clinical research and regulatory consulting services. Similar to NAMSA, Reimbursement Strategies concentrates on reimbursement strategy, health economics, medical policy research, and coverage advocacy. The companies have worked together for some time.
At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos.
Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston.